Medmira Stock Beta
| 47M Stock | EUR 0.05 0 5.75% |
MedMira fundamentals help investors to digest information that contributes to MedMira's financial success or failures. It also enables traders to predict the movement of MedMira Stock. The fundamental analysis module provides a way to measure MedMira's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to MedMira stock.
MedMira |
MedMira Company Beta Analysis
MedMira's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current MedMira Beta | 10.61 |
Most of MedMira's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, MedMira is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, MedMira has a Beta of 10.6066. This is much higher than that of the Healthcare sector and notably higher than that of the Biotechnology industry. The beta for all Germany stocks is notably lower than that of the firm.
MedMira Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses MedMira's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of MedMira could also be used in its relative valuation, which is a method of valuing MedMira by comparing valuation metrics of similar companies.MedMira is currently under evaluation in beta category among its peers.
As the market goes up, the company is expected to outperform it. However, if the market returns are negative, MedMira will likely underperform.
MedMira Fundamentals
| Return On Asset | -0.23 | |||
| Profit Margin | (2.27) % | |||
| Operating Margin | (1.79) % | |||
| Current Valuation | 34.88 M | |||
| Shares Outstanding | 697.45 M | |||
| Shares Owned By Insiders | 70.39 % | |||
| Price To Sales | 29.64 X | |||
| Revenue | 952.13 K | |||
| Gross Profit | (512.51 K) | |||
| EBITDA | (1.07 M) | |||
| Net Income | (1.83 M) | |||
| Cash And Equivalents | 20.61 K | |||
| Total Debt | 40 K | |||
| Current Ratio | 0.02 X | |||
| Book Value Per Share | (0.02) X | |||
| Cash Flow From Operations | (1.88 M) | |||
| Beta | 10.61 | |||
| Market Capitalization | 62.47 M | |||
| Total Asset | 3.83 M | |||
| Net Asset | 3.83 M |
About MedMira Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze MedMira's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MedMira using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MedMira based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in MedMira Stock
MedMira financial ratios help investors to determine whether MedMira Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in MedMira with respect to the benefits of owning MedMira security.